Director, U.S. Marketing Strategy, IgAN

Boston, MA (On-site)

$194K/yr – $291K/yrSenior Level8+ years expFull time

Posted 3 days ago

Job Summary

Own and lead rare-disease marketing programs from strategy through execution, collaborating with cross-functional teams and external partners to drive impact.

Extensive experience in biotech/pharma and rare disease marketing
Strong cross-functional collaboration and stakeholder management
Data-driven optimization of marketing programs

Job Description

Requirements

Bachelor’s degree in life sciences, business, or related field
8+ years’ experience in Biotech/pharma, with at least 3+ years in rare disease or specialty marketing
Strong understanding of rare disease or specialty market dynamics, including patient journey, HCP decision-making, and access considerations
Proven ability to translate strategy into actionable, measurable marketing plans and deliver high-quality execution
Demonstrated success managing complex, cross-functional initiatives in a matrixed environment
Strong analytical capabilities and ability to leverage data and insights to optimize performance
Excellent communication, collaboration, and stakeholder management skills
Strong project management skills with ability to manage multiple priorities and timelines
Ability to engage effectively with scientific, clinical, and commercial stakeholders
Ability to travel as required to support business needs up to ~30%

Preferred

Advanced degree (MBA, PharmD, PhD, or MS)
Experience in nephrology, rare disease, or specialty therapeutics
Prior experience in launch strategy development and market shaping
Experience working across both HCP and patient engagement strategies
Demonstrated experience integrating data, analytics, and digital capabilities into marketing execution

Alexion Pharmaceuticals, Inc.

3.9 Glassdoor

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease. A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities. As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy

Founded in 1992

New Boston, Massachusetts, USA

5K employees (240 in marketing)

www.alexion.com

72% recommend to a friend

73% CEO approval